Frequency of Use and Standards of Care for the Use of Azathioprine and 6-Mercaptopurine in Treatment of Inflammatory Bowel Disease: A Systematic Review of the Literature and a Survey of Canadian Gastroenterologists
OBJECTIVE: To identify the frequency of use and appropriate monitoring guidelines for the adverse effects of azathioprine and 6-mercaptopurine (6-MP) in the therapy of patients with inflammatory bowel disease (IBD).
Saved in:
| Main Authors: | Thomas M Wallace, Sander JO Veldhuyzen van Zanten |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2001-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2001/518192 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Survey of Canadian Gastroenterologists about the Management of Barrett’s Esophagus
by: Lisa MacNeil-Covin, et al.
Published: (2003-01-01) -
6-Mercaptopurine and Inflammatory Bowel Disease: Hidden Ground for the Cytomegalovirus
by: LC Hookey, et al.
Published: (2003-01-01) -
Canadian Digestive Health Foundation Public Impact Series: Gastroesophageal Reflux Disease in Canada: Incidence, Prevalence, and Direct and Indirect Economic Impact
by: Richard N Fedorak, et al.
Published: (2010-01-01) -
Thiopurine Methyltransferase Enzyme Activity Determination before Treatment of Inflammatory Bowel Disease with Azathioprine: Effect on Cost and Adverse Events
by: Farzana A Sayani, et al.
Published: (2005-01-01) -
Heliobacter Pylori: Epidemiology, Diagnosis and Clinical Relevance
by: Sander Jo Veldhuyzen van Zanten, et al.
Published: (1993-01-01)